CRF (6-33)

Pricing Availability   Qty
Cat.No. 1607 - CRF (6-33) | Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser | CAS No. 120066-38-8
Description: CRF-binding protein inhibitor
Alternative Names: Corticotropin-Releasing Factor (6-33)
Literature (3)

Biological Activity for CRF (6-33)

CRF (6-33) is a corticotropin-releasing factor binding protein (CRFBP) inhibitor peptide; displaces CRF from CRFBP. Suppresses body weight gain and increases motor activity in obese rats in vivo.

Licensing Information

Sold with the permission of the SALK Institute

Technical Data for CRF (6-33)

M. Wt 3220.68
Formula C141H231N41O43S
Storage Desiccate at -20°C
CAS Number 120066-38-8
PubChem ID 16135485
Smiles [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for CRF (6-33)

Solubility Soluble to 1 mg/ml in water

Product Datasheets for CRF (6-33)

Certificate of Analysis / Product Datasheet
Select another batch:

References for CRF (6-33)

References are publications that support the biological activity of the product.

Heinrichs et al (2001) Dissociation of arousal-like from anxiogenic-like actions of brain corticotropin-releasing factor receptor ligands in rats. Behav.Brain Res. 122 43 PMID: 11287075

Heinrichs et al (2001) Selective stimulatory actions of corticotropin-releasing factor ligands on correlates of energy balance. Physiol.Behav. 74 5 PMID: 11564446

Jahn et al (2002) The binding protein of corticotropin-releasing factor: ligand-binding site and subunit structure. Proc.Natl.Acad.Sci.U.S.A. 99 12055 PMID: 12215497

If you know of a relevant reference for CRF (6-33), please let us know.

Keywords: CRF (6-33), CRF (6-33) supplier, CRF-binding, protein, inhibitors, inhibits, Corticotropin-Releasing, Factor, Non-Selective, Receptors, Corticotropin, Releasing, (6-33), Non-selective, CRF, 1607, Tocris Bioscience

Citations for CRF (6-33)

Citations are publications that use Tocris products.

Currently there are no citations for CRF (6-33). Do you know of a great paper that uses CRF (6-33) from Tocris? Please let us know.

Reviews for CRF (6-33)

There are currently no reviews for this product. Be the first to review CRF (6-33) and earn rewards!

Have you used CRF (6-33)?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


GPCR Product Listing

A collection of over 450 products for G protein-coupled receptors, the listing includes research tools for the study of:

  • Rhodopsin-like Receptors
  • Glutamate Receptors
  • Frizzled Receptors
  • GPCR Signaling
Peptide Hormone Receptors

Peptide Hormone Receptors Product Listing

A collection of over 200 products for peptide hormone receptors, the listing includes research tools for the study of:

  • Anterior Pituitary Regulation
  • Blood Pressure Regulation
  • Feeding and Appetite Regulation
  • Glucose Regulation
  • Peptide Hormone Processing

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.